Republic Republic Republic
  • Log in
Open account
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
Primary market Live deals Trading Buy and sell Republic Note Own a piece of Republic's upside
Republic Ventures Opportunities for accredited investors
Republic Capital Multi-stage venture firm
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward Founder Academy A complete guide to raising funds
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain
Republic Capital In-house Venture Capital fund Broker dealer Regulated capital services
Republic Republic Republic
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
  • US

  • Log in
  • Open account
All investors
Primary market Live deals Trading Buy and sell
Republic Note Own a piece of Republic's upside
Accredited only
Republic Ventures Opportunities for accredited investors
Institutional
Republic Capital Multi-stage venture firm
More
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Growth capital solutions
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward Founder Academy A complete guide to raising funds
Web3 services
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets
Tokenization Deploy your assets on-chain
Institutional services
Republic Capital In-house Venture Capital fund
Broker dealer Regulated capital services

neuromore isn't accepting new investments

neuromore’s deadline was August 31, 2023

Follow the company to stay updated on their progress, including future investment opportunities


Explore new investment opportunities:
View companies raising now
Campaign ended
Logo of neuromore

neuromore

Brain-enhancing technology to upgrade your mental health & wellness
SaaS Mental Wellness Healthtech
Facebook Telegram Twitter LinkedIn
Featured image of neuromore
Investment reservations open
$30,000
Total reserved
5
Reservations
Reserve your spot now to ensure you can invest when neuromore starts the offering.
Successfully funded and closed on August 31, 2023.
Reserve neuromore
Pitch Updates
Invest Reserve neuromore
Facebook Telegram Twitter LinkedIn
Closed on August 31, 2023. Information may not be up-to-date. Campaign closed on August 31, 2023. Information displayed may not be up-to-date.
Problem Solution Product Traction Customers Biz. model Market Competition Vision and strategy Impact Funding Founders Summary
About Team

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is considering hosting this Reg CF securities offering by neuromore co.
Loading

Hear from some of the 5 reserved investors in neuromore


Show more

Highlights


  • ⏰ Timing: 1 billion people on the planet suffer from mental health issues
  • 📈TAM: $1 trillion dollar wellness technology market (ready for disruption)
  • 💻 Technology: World-class Neuro Digital Therapeutic solution (NDTx)
  • 👩 Truth: Science-backed, brain-tech administered by Medical Doctors
  • ✅ Tested: Vetted by Universities, Governments & Fortune 500 companies
  • 🏆 Team: Conscious leadership team with exits (including a unicorn)

Problem


The mental health
endemic is sickening

Over 1 billion people on the planet today suffer
from mental health issues that interfere with daily life!(includes: 20% of adults, teens, and kids in the USA)

—
The way we've been working isn't working
—

People keep getting sicker despite advancements in medicine, pharmaceuticals, and the rising cost of health care.

According to the CDC, 48.6% of people used at at least one prescription drug in the last 30 days.   

In recent clinical trials, it was proven that antidepressants were not much better than placebo for about 85% of people. 

Researchers can’t predict the 15% who may actually benefit from antidepressants, so people are being unnecessarily exposed to the harms of pharmaceutical drugs. 

Solution


A safe,  non-invasive way to upgrade your brain today

Neuro-Digital Therapeutic (NDTx) technology solution to bring mental health and wellness to the masses. 

Tech-driven innovations in personalized medicine are now transforming human lives in ways that were never before possible, including addressing the most common mental health conditions (stress, anxiety, depression, etc.)

neuromore offers personalized, interactive experiences that instantly ignite instant and lasting change:

  • Combining neuro/biofeedback, sound healing, CBT, and interactive games for mental health optimization
  • Instant interventions with dynamic and variable experiences driven by real-time feedback loops and AI learning from brainwaves and nervous system reactions

Source: Psychiatric Times

Product


A full suite of digital experiences to optimize mental health

such as stress, anxiety, depression,
PTSD, ADHD, and more.

—
How it works
—

NDTx is a fast, easy, and effective experience that doesn't rely on big pharma, depend on drugs, complicated methods, or expensive treatments.

Now we bring it directly to you for brain-upgrades in a box.

Welcome kit

Consumer receives a welcome kit including a biosensors or Neurosity brain scanner, a QR code to download and sign in to the application, and a welcome letter outlining what they should expect from neuromore.


Onboarding/Calibration

Consumer signs up to the platform and takes an initial assessment/calibration to determine their tailored training plan. 



Interactive Neuro Digital experiences

Consumer receives an individualized training session that combines neurofeedback, biofeedback, CBT, and different entertainment techniques.


Transformation measurement 

Consumer receives regular ongoing assessments and recalibrations to show progress reports based on the individualized training plan. 


Traction


Over $5M in revenues to date from leading organizations proving our technology 

We've been learning how to deliver effective solutions for years by leveling up our product development with leading physicians, universities, governments, and companies.


Customers


neuromore is loved  💙 by 1,000+  users in 70 countries  

Neuroscientists, clinicians, academics, engineers, and more have used neuromore to power their applications across a variety of domains — including best-in-class neurofeedback systems over brain diagnostics to prevent diseases; efficacy assessment of therapy and compounds; stress and performance monitoring; research; and education.

—
The intention of this Republic crowd-funding campaign is to fund neuromore for D2C, so we can bring brain-enhancing software and solutions directly to the masses in 2023.
—

Business model


Recurring revenue subscription model 

neuromore makes it easy to try before you buy, by offering a 30-day free trial of the NDTx brain upgrade software and bio sensor prior to purchasing a $33 monthly subscription.

Our all-inclusive, signature solution is $1,499 yearly, per user and features neuromore's software-as-a-service (SaaS), hardware device (EEG), doctor consult and treatment plan, plus 'before' and 'after' mental health milestones and reports.

Add-on Telehealth services are billed through neuromore's licensed network of medical doctors and expert coaches.

Market


Mental health is one of the most costly conditions in modern medicine today


Despite advancements in medicine, and rising healthcare costs, more and more people continue to suffer daily from mental health issues.



Devices are everywhere, so we have lots of data — just no killer applications. We believe it's time to use the same technology that contributed to the problem as a solution. 

The addressable market is for software and solutions that solve mental health challenges to improve lives and our workforce is massive. Source: McKinsey & Company

Competition


 neuromore is software to automate neuro diagnosis, treatments and  research

—
Well-positioned to emerge as a market leader by modernizing medicine digitally in the 21st century.
—

neuromore is modeling market leaders like Akili Interactive, who launched EndeavorRx®, a prescription treatment for ADHD delivered through a video game. They raised $300 million and went public (NASDAQ:AKLI) in August 2022.

neuromore's major differentiation is a truly dynamic and personalized treatment experience run on real-time bio-data and biofeedback. It's a game changer!   



Vision and strategy


Imagine upgrading the human brain using software

neuromore's brain software, once only available to big businesses, is now ready for the consumer mass market.  

neuromore will soft launch NDTx in 2023. In partnership with Neurosity we will offer a 'brain-upgrade-in-a-box' like turn-key solution for use at-home or at-work. 

neuromore's growing network of brain doctors will use our software platform to diagnose and administer treatment plans. Over time, AI will learn patterns to improve experiences, the ecosystem and optimize outcomes.

—

We believe brain software offers an alternative to pills and will advance the coming digital revolution in healthcare.

—

Impact


We balance the brain, heart & nervous system for results

Brain-enhancing technology might seem futuristic but is back by decades of scientific research. For years, neuromore's software has been used by top physicians, universities, governments and Fortune 500 companies.

—
Our mission is to end the mental health endemic
—

The human brain is brilliant. We are adding 21st century technology to make it better. By improving mental health and wellness we can significantly improve peoples lives. 

Better sleep. Improved moods. Reduction in anxiety. Clearer thinking. Sharper memory. A greater sense of calm or inner peace. Increased self-esteem. Reduced risk of depression. Higher self-esteem. Increased energy. Stronger resilience.

Source: Positive Psychology

Funding


$750k raised from accredited angel investors

In addition to our grant funding, neuromore has raised $750k from accredited angel investors. And, earned $5 million dollars in revenues to fund world class product development.

We're now raising funds to launch and scale our direct-to-consumer software (SaaS) for brain-upgrade software.

—
Funding allocation
—

Funds raised on Republic will be allocated as follows:

Founders


CEO

  • Maverick software architect for Fortune 100 companies
  • Neuro-Technology expert (member of BrainMind)
  • Computer-Science @ University Stuttgart, Germany


Summary


Join us on our mission to end the mental health endemic

—
We have created the world's first digital neuro technology platform and operating system to upgrade your brain.
—

⏰ Timing
1 billion people on the planet suffer from mental health issues

💰TAM
$1 trillion dollar wellness technology market (ready for disruption)

💻 Technology
World-class Neuro Digital Therapeutic solution (NDTx)

👩 Truth
Science-backed, brain-tech administered by Medical Doctors

✅ Tested
Vetted by Universities, Governments & Fortune 500 companies

🏆 Team
Conscious leadership team with exits (including a unicorn)

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is considering hosting this Reg CF securities offering by neuromore co.

Potential perks

If neuromore launches an offering and you complete an investment, you may receive perks.
5 reservations
Reserve
$5,000
Receive
  • "I am in flow". VIP access to neuromore D2C solution in 2023. Be first in line to receive our signature solution and support from top MDs.
  • Limited (95 left of 100)
Reserve
$25,000
Receive
  • "I am in the now." VIP invitation to neuromore's Annual Leaders Forum; a private gathering of top scientists, doctors and technologists where we share and reveal the latest and greatest technologies and insights around Neuro Digital Therapeutics.
  • Limited (8 left of 8)

About neuromore

Legal Name
neuromore co
Founded
Feb 2016
Form
Delaware Corporation
Employees
8
Website
neuromore.com
Social Media
None
Headquarters
Google Map location of of neuromore
382 Northeast 191st Street , Miami, FL
Headquarters
382 Northeast 191st Street, Miami, FL, United States 33179

neuromore Team
Everyone helping build neuromore, not limited to employees

Profile picture of Patrick Hilsbos
Patrick Hilsbos
Founder
• Maverick software architect for fortune 100 companies • Neuro-technology expert (member of BrainMind) • Computer-Science @ University Stuttgart, Germany
Profile picture of Barry Stamos
Barry Stamos
CMO
• CEO of Supernova • Entrepreneur-in-Residence at 500 Global • Founder at INBOX: Sold to Responsys Pre-IPO; $1.6B exit • Built BU at Acxiom; $2.3B exit • Founding Advisor at Tuft & Needle; Exit to SSB in 2018
Profile picture of Christopher Staley
Christopher Staley
CSO
• Former Partner and Head of Investments at Fuel VC: $150M fund • Co-founding Partner at Opopop; VC-backed F&B start-up • Co-founder of major Longevity + Anti-Aging VC fund (TBA)
Profile picture of Christian Wolf
Christian Wolf
Board Member
• Previously served as Head of Global Logistics & Trade Compliance at Broadcom Ltd • Brings in over 20 years of high-tech industry experience, including international business operations and supply chain management
Profile picture of Julius Rudolph
Julius Rudolph
Head of Product
• Driven by the mission to improve mental health and increase consciousness building digital products • Broad product development, engineering, and research experience at the intersection of wearable tech, mental health, HCI, and mobile development
Profile picture of Clint Banzhaf
Clint Banzhaf
Head of Engineering
• Completed his Diploma at the University of Stuttgart using neuromore in the area of image processing and biodata processing
Profile picture of Anthony Jacquin
Anthony Jacquin
Advisor
• In his private practice, he has shown over 5,000 people how to change the way they think, feel and respond in life • He is a respected teacher of hypnosis and hypnotherapy
Profile picture of Michael Mannino
Michael Mannino
Advisor
• Chief Science Officer of the Flow Research Collective • Formerly, Director of Programs at the Institute for Data Science & Computing, University of Miami
Profile picture of Joel Murphy
Joel Murphy
Advisor
• Innovator in democratizing open- source biosensing and science hardware as former Co-Founder and CTO of OpenBCI • Currently, CTO of Cydelic, a wearables company focused on patient-monitoring during psychedelic psychotherapy
6 more team members
Patrick Hilsbos
Founder
Barry Stamos
CMO
Christopher Staley
CSO
Christian Wolf
Board Member
Julius Rudolph
Head of Product
Clint Banzhaf
Head of Engineering
Anthony Jacquin
Advisor
Michael Mannino
Advisor
Joel Murphy
Advisor
Logo of neuromore

neuromore

neuromore successfully raised $30,000 from 5 investors on August 31, 2023
Republic

Giving everyone access to early-stage startup investing

For investors
  • Why invest
  • How it works
  • FAQ
  • Risks
  • Privacy policy
  • Accessibility
  • Cookie Preferences
  • Form CRS
For startups
  • Why raise
  • Learn
  • FAQ
  • Tokenized assets
Company
  • About
  • Insights
  • Events
  • Contact
  • Security
  • We're hiring!
Dollar Refer a startup, get $2,500
Dollar Refer a startup, get $2,500

Invest in the app

Android app iOS app

Invest in the app

Android app iOS app

This site (the "Site") is owned and maintained by OpenDeal Inc., which is not a registered broker-dealer. OpenDeal Inc. does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this Site is the responsibility of, the applicable issuer of such securities. The intermediary facilitating the offering will be identified in such offering’s documentation.

All related securities activity is conducted by OpenDeal Broker LLC a registered broker-dealer, Member of FINRA and SiPC, an affiliate of OpenDeal Inc. and OpenDeal Portal LLC, located at 149 5th Avenue, 10th Floor, New York, NY 10010. Please check our background on FINRA’s BrokerCheck.

Certain pages discussing the mechanics and providing educational materials regarding regulation crowdfunding offerings may refer to OpenDeal Broker LLC and OpenDeal Portal LLC collectively as “Republic”, solely for explanatory purposes.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC make investment recommendations and no communication, through this Site, or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Investment opportunities posted on this Site are private placements of securities that are not publicly traded, involve a high degree of risk, may lose value including the total loss of invested capital, are subject to holding period requirements and are intended for investors who do not need a liquid investment. Past performance is not indicative of future results. Investors must be able to afford the loss of their entire investment. Only qualified investors, who understand the risks of early-stage investment and who meet the Republic's investment criteria may invest. Investors may be restricted to only Accredited Investors or non-U.S. persons, to invest in offerings hosted by OpenDeal Broker. Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC, nor any of their officers, directors, agents and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information on this Site or the use of information on this site. Offers to sell securities can only be made through official offering documents that contain important information about the investment and the issuers, including risks. Investors should carefully read the offering documents. Investors should conduct their own due diligence and are encouraged to consult with their tax, legal and financial advisors.

By accessing the Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. Please also see OpenDeal Broker’s Business Continuity Plan and Additional Risk Disclosures. All issuers offering securities under regulation crowdfunding as hosted by OpenDeal Portal LLC are listed on the All Companies Page. The inclusion or exclusion of an issuer on the Platform Page and/or Republic’s Homepage, which includes offerings conducted under regulation crowdfunding as well as other exemptions from registration, is not based upon any endorsement or recommendation by OpenDeal Inc, OpenDeal Portal LLC, or OpenDeal Broker LLC, nor any of their affiliates, officers, directors, agents, and employees. Rather, issuers of securities may, in their sole discretion, opt-out of being listed on the Platform Page and Homepage.

Investors should verify any issuer information they consider important before making an investment.

Investments in private companies are particularly risky and may result in total loss of invested capital. Past performance of a security or a company does not guarantee future results or returns. Only investors who understand the risks of early stage investment and who meet the Republic's investment criteria may invest.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC verify information provided by companies on this Site and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Site can be found by searching the EDGAR database, or the offering documentation located on the Site when the offering does not require an EDGAR filing.

To help the government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account. Therefore, when you use the Services we will ask for your name, address, date of birth, and other information that will allow us to identify you. We may also ask to see your driver's license, passport or other identifying documents.

Republic and its affiliates are not and do not operate or act as a bank. Certain banking services are provided by BitGo Trust Company, a South Dakota-chartered trust company and registered money services business. BitGo Trust Company is not an FDIC member. Digital (crypto) assets and investment products are not insured by the FDIC, may lose value, and are not deposits or other obligations of BitGo Trust Company and are not guaranteed by BitGo Trust Company. Terms and conditions apply.

With regard to communications by an issuer on the Site to gauge interest in a potential securities offering pursuant to the Regulation CF exemption from the registration requirements of the Securities Act, including opportunities to “reserve” securities as indications of interest in the potential offering, please note that pursuant to Regulation Crowdfunding Rule 206 (i) that no money or other consideration is being solicited thereby, and if sent in response, will not be accepted, (ii) no offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is filed and only through a registered intermediary’s platform, (iii) any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance is given after the Form C is filed, and (iv) an indication of interest is non-binding and involves no obligation or commitment of any kind.
Invest in startups using your credit card
You can invest using your credit card

Made in SF/NYC